• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Urinary chiro- and myo-inositol levels as a biological marker for type 2 diabetes mellitus.尿手性肌醇和肌醇水平作为 2 型糖尿病的生物标志物。
Dis Markers. 2012;33(4):193-9. doi: 10.3233/DMA-2012-0925.
2
Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.韩国糖尿病患者尿中肌醇/手性肌醇比值的测定。
Yonsei Med J. 2005 Aug 31;46(4):532-8. doi: 10.3349/ymj.2005.46.4.532.
3
Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.非胰岛素依赖型糖尿病患者尿中手性肌醇排泄量低。
N Engl J Med. 1990 Aug 9;323(6):373-8. doi: 10.1056/NEJM199008093230603.
4
Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.老年人血浆C肽、性别与肌醇尿排泄的关系。
Horm Metab Res. 2001 Jan;33(1):44-51. doi: 10.1055/s-2001-12626.
5
Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat.在糖尿病db/db小鼠和链脲佐菌素诱导的糖尿病大鼠中,尿中手性肌醇和肌醇的排泄量升高。
Exp Biol Med (Maywood). 2003 Sep;228(8):907-14. doi: 10.1177/153537020322800806.
6
D-chiro-inositol metabolism in diabetes mellitus.糖尿病中的D-手性肌醇代谢
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9988-92. doi: 10.1073/pnas.90.21.9988.
7
Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes.尿中手性肌醇排泄是日本II型糖尿病患者胰岛素敏感性的一项指标性标志物。
Diabetes Care. 1994 Dec;17(12):1465-8. doi: 10.2337/diacare.17.12.1465.
8
chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.手性肌醇缺乏与胰岛素抵抗:从对照和II型糖尿病受试者的尿液、血液透析液及肌肉中分离出的含手性肌醇和含肌醇的胰岛素介质的比较
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5924-8. doi: 10.1073/pnas.90.13.5924.
9
Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.与Wistar对照大鼠相比,GK 2型糖尿病大鼠组织中的肌醇向手性肌醇表异构酶活性以及手性肌醇与肌醇的比例均降低。
Biochem Biophys Res Commun. 2002 May 10;293(3):1092-8. doi: 10.1016/S0006-291X(02)00313-3.
10
The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.糖尿病大鼠肾脏介导肌醇尿和 D-手性肌醇的选择性尿分配。
Exp Biol Med (Maywood). 2015 Jan;240(1):8-14. doi: 10.1177/1535370214543064. Epub 2014 Jul 24.

引用本文的文献

1
Neurobiology and Applications of Inositol in Psychiatry: A Narrative Review.肌醇在精神病学中的神经生物学及应用:一篇叙述性综述
Curr Issues Mol Biol. 2023 Feb 20;45(2):1762-1778. doi: 10.3390/cimb45020113.
2
Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder.胰岛素信号转导作为双相障碍锂治疗机制。
Transl Psychiatry. 2022 Aug 29;12(1):350. doi: 10.1038/s41398-022-02122-6.
3
Placental Inositol Reduced in Gestational Diabetes as Glucose Alters Inositol Transporters and IMPA1 Enzyme Expression.妊娠期糖尿病胎盘肌醇减少,因为葡萄糖改变肌醇转运蛋白和 IMPA1 酶的表达。
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e875-e890. doi: 10.1210/clinem/dgaa814.
4
Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry.通过采用串联离子化质谱技术的全二维气相色谱探索额外维度,以捕获来自代谢健康和不健康肥胖患者的唾液代谢物指纹图谱。
Anal Bioanal Chem. 2021 Jan;413(2):403-418. doi: 10.1007/s00216-020-03008-6. Epub 2020 Nov 3.
5
Potential Role of Gene Regulator NFAT5 in the Pathogenesis of Diabetes Mellitus.NFAT5 在糖尿病发病机制中的潜在作用。
J Diabetes Res. 2020 Sep 15;2020:6927429. doi: 10.1155/2020/6927429. eCollection 2020.
6
SMIT (Sodium-Myo-Inositol Transporter) 1 Regulates Arterial Contractility Through the Modulation of Vascular Kv7 Channels.SMIT(肌醇钠载体 1)通过调节血管 Kv7 通道来调节动脉收缩性。
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2468-2480. doi: 10.1161/ATVBAHA.120.315096. Epub 2020 Aug 13.
7
A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome.多囊卵巢综合征代谢方面管理的治疗选择综述。
Ther Adv Endocrinol Metab. 2020 Jul 6;11:2042018820938305. doi: 10.1177/2042018820938305. eCollection 2020.
8
A Pharmacometabolomic Approach to Predict Response to Metformin in Early-Phase Type 2 Diabetes Mellitus Patients.基于代谢组学的方法预测二甲双胍早期治疗 2 型糖尿病患者的疗效。
Molecules. 2018 Jun 29;23(7):1579. doi: 10.3390/molecules23071579.
9
Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.多囊卵巢综合征:对肌醇治疗方法的见解
Front Pharmacol. 2017 Jun 8;8:341. doi: 10.3389/fphar.2017.00341. eCollection 2017.
10
The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.糖尿病大鼠肾脏介导肌醇尿和 D-手性肌醇的选择性尿分配。
Exp Biol Med (Maywood). 2015 Jan;240(1):8-14. doi: 10.1177/1535370214543064. Epub 2014 Jul 24.

尿手性肌醇和肌醇水平作为 2 型糖尿病的生物标志物。

Urinary chiro- and myo-inositol levels as a biological marker for type 2 diabetes mellitus.

机构信息

Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.

出版信息

Dis Markers. 2012;33(4):193-9. doi: 10.3233/DMA-2012-0925.

DOI:10.3233/DMA-2012-0925
PMID:22960342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3810682/
Abstract

BACKGROUND

The aim of this study was to investigate the role of the urinary chiro- and myo-inositol levels in predicting type 2 diabetes mellitus (T2DM).

SUBJECTS AND METHODS

A total of 212 normal controls and 101 type 2 diabetic patients were enrolled this study. The concentrations of urinary chiro- and myo-inositol were measured by high performance liquid chromatography/mass spectrometry.

RESULTS

The concentration of urinary chiro-inositol was significantly higher in the diabetic subjects (2.24 ± 5.18 ng/L) than those in the control group (0.38 ± 0.62 ng/L; p < 0.001). The urinary myo-inositol level of the diabetic subjects (36.95 ± 37.77 ng/L) was also significantly higher than that of the controls (8.17 ± 13.29 ng/L; p < 0.001). The urinary chiro-inositol multiplied by myo-inositol level of the diabetic subjects (148.10 ± 544.91) was significantly higher than in the controls (5.12 ± 24.15; p < 0.001). The area under the receiver operating characteristic curve for the urinary chiro-inositol multiplied by myo-inositol level to predict T2DM was 0.840 (confidence interval 0.789-0.891, p < 0.001). The cut-off value for the urinary chiro-inositol multiplied by myo-inositol level to predict T2DM was 2.20 (sensitivity 81.3%, specificity 70.3%).

CONCLUSIONS

The urinary chiro- and myo-inositol concentrations were increased in the type 2 diabetic patients and the urinary chiro- times the myo-inositol was considered to be a sufficient marker in predicting T2DM.

摘要

背景

本研究旨在探讨尿手性肌醇和肌醇水平在预测 2 型糖尿病(T2DM)中的作用。

受试者和方法

本研究共纳入 212 名正常对照者和 101 例 2 型糖尿病患者。采用高效液相色谱/质谱法测定尿手性肌醇和肌醇的浓度。

结果

糖尿病患者尿手性肌醇浓度(2.24±5.18ng/L)明显高于对照组(0.38±0.62ng/L;p<0.001)。糖尿病患者尿肌醇水平(36.95±37.77ng/L)也明显高于对照组(8.17±13.29ng/L;p<0.001)。糖尿病患者尿手性肌醇乘以肌醇水平(148.10±544.91)明显高于对照组(5.12±24.15;p<0.001)。尿手性肌醇乘以肌醇水平预测 T2DM 的受试者工作特征曲线下面积为 0.840(置信区间 0.789-0.891,p<0.001)。预测 T2DM 时,尿手性肌醇乘以肌醇水平的截断值为 2.20(敏感性 81.3%,特异性 70.3%)。

结论

2 型糖尿病患者尿手性肌醇和肌醇浓度升高,尿手性肌醇乘以肌醇被认为是预测 T2DM 的充分标志物。